Logo image of ACU.CA

AURORA SOLAR TECHNOLOGIES IN (ACU.CA) Stock Fundamental Analysis

TSX-V:ACU - TSX Venture Exchange - CA05207J1084 - Common Stock - Currency: CAD

0.015  0 (0%)

Fundamental Rating

2

ACU gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 13 industry peers in the Electronic Equipment, Instruments & Components industry. ACU has a bad profitability rating. Also its financial health evaluation is rather negative. ACU is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ACU had negative earnings in the past year.
ACU had a negative operating cash flow in the past year.
ACU had negative earnings in each of the past 5 years.
ACU had negative operating cash flow in 4 of the past 5 years.
ACU.CA Yearly Net Income VS EBIT VS OCF VS FCFACU.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1M -2M -3M -4M

1.2 Ratios

ACU has a Return On Assets of -4.62%. This is comparable to the rest of the industry: ACU outperforms 46.15% of its industry peers.
ACU has a Return On Equity of -7.98%. This is in the better half of the industry: ACU outperforms 61.54% of its industry peers.
Industry RankSector Rank
ROA -4.62%
ROE -7.98%
ROIC N/A
ROA(3y)-60.95%
ROA(5y)-57.86%
ROE(3y)-85.08%
ROE(5y)-79.34%
ROIC(3y)N/A
ROIC(5y)N/A
ACU.CA Yearly ROA, ROE, ROICACU.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300

1.3 Margins

With an excellent Gross Margin value of 57.99%, ACU belongs to the best of the industry, outperforming 92.31% of the companies in the same industry.
ACU's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for ACU so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 57.99%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y31.07%
GM growth 5Y13.48%
ACU.CA Yearly Profit, Operating, Gross MarginsACU.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

More info and screens

2

2. Health

2.1 Basic Checks

ACU does not have a ROIC to compare to the WACC, probably because it is not profitable.
ACU has about the same amout of shares outstanding than it did 1 year ago.
ACU has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ACU is higher compared to a year ago.
ACU.CA Yearly Shares OutstandingACU.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
ACU.CA Yearly Total Debt VS Total AssetsACU.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

Based on the Altman-Z score of -1.37, we must say that ACU is in the distress zone and has some risk of bankruptcy.
ACU has a Altman-Z score of -1.37. This is in the lower half of the industry: ACU underperforms 69.23% of its industry peers.
ACU has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.02, ACU belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z -1.37
ROIC/WACCN/A
WACC7.61%
ACU.CA Yearly LT Debt VS Equity VS FCFACU.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M

2.3 Liquidity

A Current Ratio of 1.96 indicates that ACU should not have too much problems paying its short term obligations.
With a Current ratio value of 1.96, ACU perfoms like the industry average, outperforming 53.85% of the companies in the same industry.
ACU has a Quick Ratio of 1.96. This is a bad value and indicates that ACU is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of ACU (0.88) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.96
Quick Ratio 0.88
ACU.CA Yearly Current Assets VS Current LiabilitesACU.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

4

3. Growth

3.1 Past

ACU shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 90.91%, which is quite impressive.
Looking at the last year, ACU shows a very strong growth in Revenue. The Revenue has grown by 46.68%.
Measured over the past years, ACU shows a very strong growth in Revenue. The Revenue has been growing by 90.22% on average per year.
EPS 1Y (TTM)90.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-122.22%
Revenue 1Y (TTM)46.68%
Revenue growth 3Y80.16%
Revenue growth 5Y90.22%
Sales Q2Q%-0.78%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ACU.CA Yearly Revenue VS EstimatesACU.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ACU.CA Yearly EPS VS EstimatesACU.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
ACU.CA Price Earnings VS Forward Price EarningsACU.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ACU.CA Per share dataACU.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.01 0.02 0.03 0.04

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ACU does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AURORA SOLAR TECHNOLOGIES IN

TSX-V:ACU (3/6/2025, 7:00:00 PM)

0.015

0 (0%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)02-26 2025-02-26
Earnings (Next)07-28 2025-07-28
Inst Owners10.16%
Inst Owner ChangeN/A
Ins Owners2.28%
Ins Owner ChangeN/A
Market Cap3.33M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.31
P/FCF N/A
P/OCF N/A
P/B 0.59
P/tB 0.78
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.05
BVpS0.03
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.62%
ROE -7.98%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 57.99%
FCFM N/A
ROA(3y)-60.95%
ROA(5y)-57.86%
ROE(3y)-85.08%
ROE(5y)-79.34%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y31.07%
GM growth 5Y13.48%
F-Score4
Asset Turnover1.12
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 102.33%
Cap/Sales 4.8%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.96
Quick Ratio 0.88
Altman-Z -1.37
F-Score4
WACC7.61%
ROIC/WACCN/A
Cap/Depr(3y)68.14%
Cap/Depr(5y)56.81%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)90.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-122.22%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)46.68%
Revenue growth 3Y80.16%
Revenue growth 5Y90.22%
Sales Q2Q%-0.78%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y86.1%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y50.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y63.61%
OCF growth 3YN/A
OCF growth 5YN/A